The effects of compounds interfering with gamma-secretase, the enzymatic complex responsible of the formation of the amyloid-beta (A beta) peptide from amyloid-beta protein precursor (A beta PP), on plaque deposition in transgenic mouse models of Alzheimer's disease are known but scanty data are available on the effects of these drugs on brain plasticity. We evaluated the effects of long-term treatment with CHF5074, a new gamma-secretase modulator, on hippocampal neurogenesis, cortical synaptophysin levels, and contextual memory in transgenic mice carrying the double Swedish mutation of A beta PP (Tg2576). Six-month old Tg2576 mice were treated with CHF5074 (375 ppm in the diet) up to 15 months of age. Age-matched control transgenic and wild-type mice received standard diet. Compared to wild-type animals, transgenic controls showed a significant decrease in the number of doublecortin-positive neuroblasts in dentate gyrus, synaptophysin intensity in the cortex, freezing to context in the contextual fear conditioning test. Compared to transgenic controls, CHF5074 treatment of Tg2576 mice resulted in a significant attenuation of the neurogenesis impairment in hippocampus (p - 0.036), normalization of synaptophysin levels in cortex (p < 0.001), attenuation of plaque burden in the cortex (p = 0.033), increases astroglial reaction around plaques (p = 0.001), and attenuation of activated microglia (p = 0.040). These effects were associated to a complete reversal of contextual memory deficit (p = 0.006). Contextual memory significantly correlated with synaptophysin immunoreactivity in the cortex (r = 0.548, p = 0.0038).

CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease / B. P., Imbimbo; L., Giardino; S., Sivilia; A., Giuliani; M., Gusciglio; Pietrini, Vladimiro; E., Del Giudice; A., D'Arrigo; A., Leon; G., Villetti; L., Calzà. - In: JOURNAL OF ALZHEIMER'S DISEASE. - ISSN 1387-2877. - 20(1):(2010), pp. 159-173. [10.3233/JAD-2010-1366]

CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease

PIETRINI, Vladimiro;
2010-01-01

Abstract

The effects of compounds interfering with gamma-secretase, the enzymatic complex responsible of the formation of the amyloid-beta (A beta) peptide from amyloid-beta protein precursor (A beta PP), on plaque deposition in transgenic mouse models of Alzheimer's disease are known but scanty data are available on the effects of these drugs on brain plasticity. We evaluated the effects of long-term treatment with CHF5074, a new gamma-secretase modulator, on hippocampal neurogenesis, cortical synaptophysin levels, and contextual memory in transgenic mice carrying the double Swedish mutation of A beta PP (Tg2576). Six-month old Tg2576 mice were treated with CHF5074 (375 ppm in the diet) up to 15 months of age. Age-matched control transgenic and wild-type mice received standard diet. Compared to wild-type animals, transgenic controls showed a significant decrease in the number of doublecortin-positive neuroblasts in dentate gyrus, synaptophysin intensity in the cortex, freezing to context in the contextual fear conditioning test. Compared to transgenic controls, CHF5074 treatment of Tg2576 mice resulted in a significant attenuation of the neurogenesis impairment in hippocampus (p - 0.036), normalization of synaptophysin levels in cortex (p < 0.001), attenuation of plaque burden in the cortex (p = 0.033), increases astroglial reaction around plaques (p = 0.001), and attenuation of activated microglia (p = 0.040). These effects were associated to a complete reversal of contextual memory deficit (p = 0.006). Contextual memory significantly correlated with synaptophysin immunoreactivity in the cortex (r = 0.548, p = 0.0038).
2010
CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease / B. P., Imbimbo; L., Giardino; S., Sivilia; A., Giuliani; M., Gusciglio; Pietrini, Vladimiro; E., Del Giudice; A., D'Arrigo; A., Leon; G., Villetti; L., Calzà. - In: JOURNAL OF ALZHEIMER'S DISEASE. - ISSN 1387-2877. - 20(1):(2010), pp. 159-173. [10.3233/JAD-2010-1366]
File in questo prodotto:
File Dimensione Formato  
Pietrini, JAD 2010.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 2.44 MB
Formato Adobe PDF
2.44 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2299708
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 75
  • ???jsp.display-item.citation.isi??? 73
social impact